[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591205":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":36,"responsibleParty":51,"collaborators":20,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":20,"eligibilityCriteria":58,"healthyVolunteers":55,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":20,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":20,"overallStatus":71,"whyStopped":20,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Yunnan Cancer Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"The application value of spectral CT in the accurate staging of liver cancer","EXPERIMENTAL","Prospectively collect medical images and clinical data related to liver cancer using Philips Quark CT equipment, and evaluate the diagnostic accuracy and clinical application value in the accurate staging of liver cancer.Patients diagnosed with liver cancer in Yunnan Provincial Cancer Hospital from April 2025 to May 2026 were consecutively included, and after scanning with Philips Quark CT, the TNM stage of liver cancer patients was assessed by two radiologists, and finally statistical analysis was performed.",[13],"Diagnostic Test: To explore the value of spectral CT in the diagnosis and treatment of liver cancer",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DIAGNOSTIC_TEST","To explore the value of spectral CT in the diagnosis and treatment of liver cancer","The CT scan is part of the standard treatment protocol.",[9],null,[22],{"name":23,"affiliation":24,"role":25},"Lianhua Ye","Ethics Committee of Yunnan Provincial Cancer Hospital","STUDY_DIRECTOR",[27,32],{"name":28,"role":29,"phone":30,"phoneExt":20,"email":31},"Xumin Liu","CONTACT","+8615974863526","2020429055@kmmu.edu.cn",{"name":33,"role":29,"phone":34,"phoneExt":20,"email":35},"Zhenhui Li","+8613698736132","lizhenhui@kmmu.edu.cn",[37],{"facility":5,"status":20,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Kunming","Yunnan","650118","China","CN",{"type":44,"coordinates":45},"Point",[46,47],102.71833,25.03889,{"lat":47,"lon":46},[50],{"name":28,"role":29,"phone":30,"phoneExt":20,"email":31},{"type":52,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100591205","the-application-value-of-spectral-ct-in-the-accurate-staging-of-liver-cancer-100591205",false,"NCT06977399","The Application Value of Spectral CT in the Accurate Staging of Liver Cancer","Inclusion Criteria:\n\n1. Undergo a contrast-enhanced Quark Spectral CT scan of the lower abdomen\u002Fpelvis within 1 week before treatment.\n2. Age \\> 18 years.\n3. Patients suspected of having liver cancer.\n4. Patients who have signed the informed consent form.\n\nExclusion Criteria:\n\n1. Severe cardiac, pulmonary, or renal insufficiency.\n2. Allergy to iodine-based contrast agents.\n3. Inability to cooperate with the CT examination.\n4. Poor image quality of the Quark Spectral CT scan.\n5. Women who are pregnant or breastfeeding.","ALL","18 Years","80 Years",{"count":63,"type":64},150,"ESTIMATED","INTERVENTIONAL",[67],"NA","Spectral CT was used to prospectively collect medical images and clinical data related to liver cancer, evaluate the effect of image quality in the diagnosis of liver cancer, and evaluate the application value in the accurate staging of liver cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.",[70],"Liver Cancer","NOT_YET_RECRUITING","2025-05-16",{"date":74,"type":75},"2025-05-18","ACTUAL",{"date":77,"type":64},"2025-06-01",{"date":79,"type":64},"2026-05-31",{"name":5,"class":6},1]